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A Report of Guillain–Barré Syndrome With Myalgia and Mild Weakness
Abstract
We report a rare case that revealed severe myalgia as the chief complaint that is 
not mentioned in the list of frequent symptoms of Guillain Barré. 
Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating 
polyneuropathy (AIDP).Required features for diagnosis of GBS are progressive 
motor weakness of more than one limb and areflexia. We report an 11-year-
old boy who was referred to the emergency department with complaints of 
generalized body pain and gate problem. 
It seems that if myalgias are the chief complaint and weakness is mentioned as 
a less important symptom, clinicians should consider GBS after ruling out other 
reasons for myalgia especially inflammatory myositis.
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CASE REPORT
Introduction
Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating 
polyneuropathy (AIDP), an autoimmune disease affecting the peripheral nervous 
system that causes ascending paralysis and the loss of deep tendon reflexes (1).
It is a heterogeneous group of disorders with similar clinical presentations. Typically, 
it is an acute, self-limited illness, which peaks in 2 to 4 weeks and then subsides 
(2). The pathogenesis of GBS remains unclear. Increasing data indicate that it is an 
autoimmune disease, often triggered by a preceding viral or bacterial infection with 
organisms such as Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, or 
Mycoplasma pneumoniae. Vaccination against the flu, rabies, and meningitis are 
also documented precipitating factors that have been reported (3).
Since poliomyelitis has nearly been eliminated, the Guillain–Barré syndrome is 
currently the most frequent cause of acute childhood flaccid paralysis worldwide 
and constitutes one of the serious emergencies in neurology (4).
Men are1.5 times more likely to be affected than women, and the incidence 
increases with age from1 per 100,000 in those below30 years of age to about4 cases 
per100,000 in those older than 75 years of age (5).
The natural history of GBS in infants and children is more variable and more benign 
than in adults. Although, affected children usually recover in a shorter time than 
adults do. However, the mortality rate has been reported as3-5% (6).
Required features for diagnosis of GBS are progressive motor weakness of more than 
one limb and areflexia. In addition, the existence of the progression of weakness, 
relative symmetry, mild sensory symptoms, or signs and cranial involvement could 
strongly support diagnosis (7).
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(concomitant blood sugar:100)
Lumbosacral MRI: normal
Technetium bone scan: normal
EMG NCV: Diagnostic for Guillain-Barré (Demyelinating
 polyneuropathy)
Repeated EMG NCV: Diagnostic for Guillain-Barré 
(Demyelinating polyneuropathy)
From the laboratory results and positive (EMGNCV) 
tests, Guillain Barré was diagnosed and he was treated 
with standard drugs and released after10days. In a follow 
up, he mentioned no weakness, he could walk, and his 
pain was decreased. 
Discussion
As GBS is a heterogeneous group of disorders with 
similar clinical presentations and has challenges 
regarding itsdiagnosis (2), a thorough medical 
assessment may be needed to aid clinicians to 
differentiate symptoms and signs of GBS from other 
diagnoses.
According to the literature, required features for diagnosis 
of GBS are progressive motor weakness of more than 
one limb, areflexia, the existence of progression of 
weakness, relative symmetry, mild sensory symptoms or 
signs, and cranial involvement could strongly support its 
presence7.
These features were similar with the results mentioned 
by Ismael et al that revealed clinical manifestations 
of28 children diagnosed as GBS were motor weakness 
(100%), cranial nerves involvement(14.29%), and 
disturbance of sensation(17.80%) (6).
In addition, in a series of49 children hospitalized with 
GBS, not surprisingly, weakness was the most common 
initial complaint and, then, pain (particularly in the back 
and lower extremities) was a prominent feature (7). 
Furthermore, Hicks et al identified 35 pediatric patients 
with Guillain-Barré that showed that the most common 
presentation of symptoms were paresthesis(54%), 
weakness(49%), and  Myalgias (49%). Sensation 
was affected in54% of patients and hyporeflexia or 
areflexia were present in 94% of patients. Cranial nerve 
dysfunction (46%).also, and autonomic involvement 
e.g., changes in blood pressure, pulse, or bowel/bladder 
control) were also common (9).
Borade et al. indicated a case that presented a GBS2-
Meanwhile, the main feature is progressive bilateral 
and relatively symmetric weakness of the limbs that 
progresses over a period of12 hours to28 days before a 
plateau is reached (8).
However, in this report, investigators report a rare case 
that revealed severe Myalgia as the chief complaint 
that is not mentioned in thelist of frequent symptoms of 
GuillainBarré. 
Case report
An 11-year-old boy was referred to the emergency 
department with complaints of generalized body pain 
and gate problems. He revealed a history of URI in 
the preceding 2weeks and mentioned generalized body 
pain3 days prior to admission and gate problems from 
the day before. No past medical history or family history 
were mentioned.
In a systemic examination, his vital signs were stable 
and generalized muscle tenderness existed. 
Other systemic examinations were normal.
A neurological examination showed normal mental 
status, cranial nerve, and sensory examination.
The deep tendon reflex (DTR) in upper limbs and lower 
limbs were diminished (+1) and the proximal and distal 
muscle force in the upper and lower limbs were4/5. He 
could not walk due to severe pain.
The patient mentioned pain as chief complaint, which 
is rare. The clinicians performed two electromyography 
(EMG) and nerve conduction velocity (NCV) tests to 
ensure the diagnosis.













CSF exam:WBC:0, RBC:0,Protein:55,Glucose:80 
Guillain–Barré syndrome with Myalgia
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year-old male child admitted to hospital with a history 
of acute onset of bilateral lower limb progressive leg 
weakness and difficulty in walking and standing. In this 
study, no complaint of pain was mentioned (10).
Although the disease is characterized by a rapidly 
ascending weakness, some variants present with atypical 
clinical features1.
Roodbol et al conducted a study with 23 preschool 
children and in32 older children with GBS. Their results 
mentioned that for preschool children, refusal to walk 
and pain in the legs was the most frequent presenting 
symptom (65%),while older children presented with 
more classic symptoms of weakness and paresthesias 
(11). 
Although,in some of these investigations pain was 
indicated as a GBS feature. It should be mentioned that 
in these cases, patients who encountered pain that was 
accompanied by other frequent symptoms of GBS and 
Guillain-Barré syndrome pain involvement had not 
been considered as a major clinical manifestation for 
diagnostic criteria among children, which differs with 
our study. Our study shows no other symptoms except 
pain.
Myalgia had not been considered a chief and common 
complaint of GBS. Often patients report weakness with 
or without myalgia. However, results showed that if 
myalgias were the chief complaint and weakness was 
mentioned as a lessimportant symptom, clinicians should 
consider GBS after ruling out other reasonsfor myalgia 
especially inflammatory myositis. Hence, a thorough 
assessment of effective factors that can treat weakness 
and gate disability sooner and preserve patient life better 
is of clinical significance.
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